Physician profile
Allison E Murchison
NPI 1083699573
$1,887.03
in general payments reported to CMS, 2019-2025
16 companies · $285 in 2025
The $285 reported for 2025 was less than what a typical Ophthalmology provider received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $429 · 2020: $177 · 2021: $175 · 2022: $191 · 2023: $381 · 2024: $249 · 2025: $285.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $915.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $914.89 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $579.88 | 2019-2025 | Hydrus Microstent, Centurion, Clareon |
| Johnson & Johnson Surgical Vision, INC. | $181.85 | 2019-2025 | Veritas Vision System |
| Glaukos Corporation | $142.66 | 2020-2023 | Istent Inject Trabecular Micro-Bypass System |
| Bausch & Lomb Americas INC. | $133.91 | 2024-2025 | Miebo, Xiidra, Vyzulta |
| Horizon Therapeutics Plc | $116.73 | 2023 | Tepezza |
| Allergan, INC. | $114.85 | 2019-2022 | |
| Abbvie INC. | $97.25 | 2022-2023 | |
| Novartis Pharmaceuticals Corporation | $96.69 | 2019-2022 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $93.08 | 2019 | |
| Tarsus Pharmaceuticals, INC. | $76.80 | 2024-2025 | Xdemvy |
| Amgen INC. | $64.52 | 2025 | Tepezza |
| Aerie Pharmaceuticals, INC. | $64.22 | 2019-2020 | |
| Shire North American Group INC | $45.78 | 2019 | |
| Sun Pharmaceutical Industries INC. | $38.70 | 2019 | |
| Thea Pharma INC. | $20.53 | 2022 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Carl Zeiss Meditec, INC. | $19.58 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Allison Murchison listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.